An expert discusses how the treatment landscape for lower-risk MDS has evolved with multiple new options including luspatercept, imetelstat, and lenalidomide based on specific patient characteristics ...

Researchers are developing AI programmes to make doping detection more effective, faster, and cheaper. How do these systems ...